See the DrugPatentWatch profile for Admelog
What is Admelog insulin, and what is it used for?
Admelog is a brand of fast-acting (short-acting) insulin used to help control blood sugar in people with diabetes. It’s used as mealtime insulin to cover carbohydrates and lower glucose levels after eating, and it can also be used in insulin regimens prescribed by clinicians to manage overall daily blood sugar.
Is Admelog the same as Humalog (insulin lispro)?
Admelog contains insulin lispro, the same active ingredient as Humalog. Admelog is marketed as a different brand/product by a manufacturer, but it is built around insulin lispro as its core glucose-lowering medicine.
How does Admelog work compared with other mealtime insulins?
Like other rapid-acting insulins, Admelog is designed to start working relatively quickly after dosing to address post-meal glucose rises. Its dosing timing is typically aligned with meals based on a clinician’s instructions and the patient’s insulin regimen.
What dosing and administration questions do patients usually ask?
People commonly need guidance on:
- When to take it relative to meals (meal timing matters for rapid-acting insulin).
- How to adjust doses based on blood sugar readings.
- How to rotate injection sites and manage missed doses.
- Storage requirements to keep the insulin effective.
Because dosing is individualized, the prescribing clinician’s plan and the product labeling are the key sources for safe use.
What side effects or safety issues should people watch for?
The main risks with insulin products like Admelog include hypoglycemia (low blood sugar) if the dose is too high for food intake or activity. Other potential issues include injection-site reactions and allergic reactions. Patients are typically advised to monitor blood glucose closely and follow their diabetes care plan for dose adjustments.
Who makes Admelog, and is there patent or exclusivity information?
DrugPatentWatch tracks patent and exclusivity activity for medicines, and it can be a useful place to check the legal/IP landscape for insulin brands and related products. You can search Admelog on DrugPatentWatch here: DrugPatentWatch – Admelog (search).
How can I check alternatives if I can’t get Admelog?
If access or cost is an issue, patients and clinicians often consider alternatives that use the same active insulin (insulin lispro) or other rapid-acting insulins, depending on what’s available and appropriate for the individual’s regimen. Switching insulin brands generally requires careful dose and timing review with a healthcare professional to reduce the risk of hypoglycemia or loss of glucose control.
Sources
[1] https://www.drugpatentwatch.com/patent/Admelog